Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. fibrosis chronic
Show results for

Refine by

Fibrosis Chronic Articles & Analysis

5 news found

Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico`s Proprietary End-to-end Artificial Intelligence Platform

Insilico Medicine Initiates First-in-Human Study of ISM001-055, a Novel Drug Discovered Using Insilico`s Proprietary End-to-end Artificial Intelligence Platform

It is being developed for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic lung disease which results in progressive and irreversible decline in lung function. ...

ByInsilico Medicine


Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital

Lung Therapeutics Receives SBIR Award for Kidney Fibrosis Research; Principal Investigator BreAnne Mackenzie Will Speak at 4th Annual IPF Summit 2020/Digital

Addressing an Unmet Medical Need There is a great need for treatments targeting fibrosis related to Chronic Kidney Disease (CKD). Kidney fibrosis (KF) is a pathological hallmark of CKD and a major contributing factor to progression to end-stage CKD. ...

ByLung Therapeutics, Inc.


Feldan therapeutics announces a publication in nature communications

Feldan therapeutics announces a publication in nature communications

McCray’s team on the delivery of proteins to airway cells and in vivo models, aiming to advance new therapeutic avenues in the treatment of pulmonary diseases such as cystic fibrosis, asthma and chronic obstructive pulmonary disease (COPD). Researchers involved are experts in airway epithelial cells, pulmonary biology, lung diseases, as well as recombinant ...

ByFeldan Therapeutics


Lung Therapeutics, Inc. Raises $36 Million in Series C Financing to Advance Clinical Pipeline

Lung Therapeutics, Inc. Raises $36 Million in Series C Financing to Advance Clinical Pipeline

” LTI-03 – Potential to Dramatically Improve Patient Health in IPF Idiopathic Pulmonary Fibrosis (IPF) is a chronic lung disease with progressive scarring in the lungs from unknown causes such as disease, injury or genetics. ...

ByLung Therapeutics, Inc.


Abbott awards scholarships to students living with cystic fibrosis to help them pursue their dreams

Abbott awards scholarships to students living with cystic fibrosis to help them pursue their dreams

Abbott today awarded the 2010 Thriving Student Achiever Scholarship to Jason Egbert, a student with cystic fibrosis who demonstrates exceptional academic achievement, community service, creative and artistic talent and passion for inspiring others. Jason Egbert from Rexburg, Idaho, was selected for the Thriving Student Achiever Scholarship from a group of 40 outstanding students ...

ByCSRwire - Corporate Social Responsibility Newswire

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT